Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 2Terminated 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Pancreatic Neoplasms 9Carcinoma, Non-Small-Cell Lung 7Rectal Neoplasms 6Colorectal Neoplasms 6Breast Neoplasms 6Neoplasms 5Glioblastoma 5Squamous Cell Carcinoma of Head and Neck 4Ovarian Neoplasms 4Head and Neck Neoplasms 4Stomach Neoplasms 3Oligodendroglioma 3Mouth Neoplasms 3Lung Neoplasms 3Glioma 3Esophageal Neoplasms 3Astrocytoma 3Urinary Bladder Neoplasms 2Sarcoma 2Neoplasm Metastasis 2Meningioma 2Melanoma 2Gliosarcoma 2Glioma, Subependymal 2Fallopian Tube Neoplasms 2Ependymoma 2Carcinoma, Squamous Cell 2Carcinoma, Ovarian Epithelial 2Adenocarcinoma Of Esophagus 2Xerostomia 1

Interventions

pembrolizumab 11epacadostat 2Paclitaxel 2spartalizumab 1ribociclib 1Surgical Procedures, Operative 1Saline Solution 1Radiosurgery 1Prednisone 1Pemetrexed 1Nivolumab 1Immunotherapy 1Gemcitabine 1Docetaxel 1Dexamethasone 1Cisplatin 1Carboplatin 1Calcium Dobesilate 1Axitinib 1AZD 6244 12-(2-furanyl)-7-(2-(4-(4-(2-methoxyethoxy)phenyl)-1-piperazinyl)ethyl)-7H-pyrazolo(4,3-e)(1,2,4)triazolo(1,5-c)pyrimidine-5-amine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Parkinson Disease 4, Autosomal Dominant Lewy Body × Surgical Procedures, Operative × Clear all
NCT03116529 2024-11-04

NEXIS

University of Maryland, Baltimore

Phase 1/2 Terminated
22 enrolled
Sarcoma

Diabetes Mellitus, Insulin-Dependent, 12, Parkinson Disease 4, Autosomal Dominant Lewy Body, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡